$XRAY SEC Filings

Filed On	Filing
09 Oct 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
02 Oct 2026	Form 4: Mazelsky Jonathan Jay, Director Granted 3,323.4332 Phantom Stock (Directors' Deferred Compensation) DDC ($30K)
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	SCHEDULE 13G
12 Aug 2026	Form 4: Fortson John C., EVP & CFO Received 24,014 shares as a grant or award · Granted 104,200 Stock Option (Right to Buy)
11 Aug 2026	Form 4: Frohning Andrea L., SVP, CHRO Gave up 802 shares to cover exercise price or tax ($9.72K)
07 Aug 2026	8-K/A: Results of Operations and Financial Condition
06 Aug 2026	10-Q
06 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	8-K: Financial Statements and Exhibits
21 Jul 2026	Form 3: Fortson John C., EVP & CFO No securities owned
08 Jul 2026	SCHEDULE 13G/A
01 Jul 2026	Form 4: Mazelsky Jonathan Jay, Director Granted 2,841.8303 Phantom Stock (Directors' Deferred Compensation) DDC ($30K)
26 Jun 2026	S-8
18 Jun 2026	Form 4/A: Mazelsky Jonathan Jay, Director Bought 10,000 shares ($101K)
18 Jun 2026	Form 3: Barton-Brobst Lindi Rene, SVP, GC & Secretary Holds 45,185.444 shares of Common Stock
16 Jun 2026	Form 4: Hosein Clyde, Director Bought 6,500 shares ($64.9K)
15 Jun 2026	Form 4: Mckeon Brian P, Director Bought 10,000 shares ($101K)
15 Jun 2026	Form 4: Gladden Brian T, Director Bought 9,985.022 shares ($100K)
15 Jun 2026	Form 4: Mazelsky Jonathan Jay, Director Received 10,000 shares as a grant or award ($101K)

Comments